Global Alzheimer’s Drugs Market Report By Drugs (Donepezil, Rivastigmine, Galantamine And Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies And E-Commerce) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210350
January 2020
Report Formats:

As per this study the Global Alzheimer’s Drugs Market was valued USD X,XXX.X MN (by revenue) in 2019 and is anticipated to reach USD X,XXX.X MN by 2026 with a CAGR of X%.
 
Alzheimer is a chronic neurodegenerative disease that leads to a decrease in the ability to memorize and think. Alzheimer is a progressive disease with dementia as a primary symptom that worsens with increasing age. Drugs used to treat are basically cholinesterase inhibitors are unable to cure Alzheimer completely but leads to a reduction in primarily symptoms and control patients’ behavior to a certain extent.
 
Market Dynamics
 
Rising count of geriatric population coupled with the growing prevalence of disease in western nations is driving the market demand. Rising awareness regarding treatment and medication for chronic diseases is again fueling the market growth. Also, an increasing collaboration of major players for the development of better drugs to cure Alzheimer is likely to boost the market growth in the forecasting period. However, the high cost of advanced drugs is anticipated to setback the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of alzheimer’s drugs.
 
Market Segmentation
 
The broad alzheimer’s drugsmarket has been sub-grouped into drugs and distributional channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Drugs

  • Donepezil
  • Rivastigmine
  • Galantamine
  • Others
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for alzheimer’s drugs in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Alzheimer’s Drugs Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the alzheimer’s drugs market include Daichi Sankyo Company Limited, Eisai Co. Ltd., Janssen Pharmaceuticals, Lundbeck A/S, Novartis International AG, Pfizer, Inc., and Teva Pharmaceuticals Industries Ltd among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

TABLE OF CONTENTS
 
1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Alzheimer’S Drugs Market
       2.2. Global Alzheimer’S Drugs Market Snapshot
 
3 . ALZHEIMER’S DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Alzheimer’S Drugs Market
       3.3. Market Restraints of Alzheimer’S Drugs Market
       3.4. Opportunities of Alzheimer’S Drugs Market
       3.5. Trends of Alzheimer’S Drugs Market
       3.6. Porter’s Five Force Analysis of Alzheimer’S Drugs Market
       3.7. Alzheimer’S Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by By Drugs
           3.7.2 Market Attractive Analysis by By Distribution Channel
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Alzheimer’S Drugs Value Chain Analysis
       4.2. Alzheimer’S Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Alzheimer’S Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Alzheimer’S Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL ALZHEIMER’S DRUGS MARKET ANALYSIS BY BY DRUGS
       5.1 Overview by By Drugs
       5.2 Global Alzheimer’S Drugs Market Analysis by By Drugs
       5.3 Market Analysis of Donepezil by Regions
       5.4 Market Analysis of Rivastigmine by Regions
       5.5 Market Analysis of Galantamine by Regions
       5.6 Market Analysis of Others by Regions
 
6 . GLOBAL ALZHEIMER’S DRUGS MARKET ANALYSIS BY BY DISTRIBUTION CHANNEL
       6.1 Overview by By Distribution Channel
       6.2 Global Alzheimer’S Drugs Market Analysis by By Distribution Channel
       6.3 Market Analysis of Hospital Pharmacies by Regions
       6.4 Market Analysis of Retail Pharmacies by Regions
       6.5 Market Analysis of E-Commerce by Regions
 
7 . GLOBAL ALZHEIMER’S DRUGS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Alzheimer’S Drugs Market Estimate by Market Segment
           7.3.3. North America Alzheimer’S Drugs Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Alzheimer’S Drugs Market Estimate by Market Segment
           7.4.3. Europe Alzheimer’S Drugs Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Alzheimer’S Drugs Market Estimate by Market Segment
           7.5.3. Asia Pacific Alzheimer’S Drugs Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Alzheimer’S Drugs Market Estimate by Market Segment
           7.6.3. Latin America Alzheimer’S Drugs Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Alzheimer’S Drugs Market Estimate by Market Segment
           7.7.3. Middle East & Africa Alzheimer’S Drugs Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE ALZHEIMER’S DRUGS COMPANIES
       8.1. Alzheimer’S Drugs Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF ALZHEIMER’S DRUGS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Daichi Sankyo Company Limited
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Eisai Co. Ltd
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Janssen Pharmaceuticals
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. Lundbeck A/S
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Novartis International AG
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Pfizer, Inc.
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Teva Pharmaceuticals Industries Ltd
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Alzheimer’S Drugs Market Snapshot
  • Drivers of The Global Alzheimer’S Drugs Market Impact Analysis
  • Restraints of The Global Alzheimer’S Drugs Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Global Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Donepezil by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Rivastigmine by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Galantamine by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Others by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis by By Distribution Channel (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in E-Commerce by Geography (USD MN)
  • Global Alzheimer’S Drugs Market by Geography (USD MN)
  • North America Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • North America Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • North America Alzheimer’S Drugs Market Estimate by Country (USD MN)
  • United State Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • United State Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Rest of North America Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Rest of North America Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Europe Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Europe Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • United Kingdom Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • United Kingdom Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • France Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • France Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Germany Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Germany Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Rest of Europe Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Rest of Europe Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Asia Pacific Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Asia Pacific Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Asia Pacific Alzheimer’S Drugs Market Estimate by Country (USD MN)
  • China Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • China Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Japan Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Japan Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • India Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • India Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Rest of Asia Pacific Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Rest of Asia Pacific Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Latin America Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Latin America Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Latin America Alzheimer’S Drugs Market Estimate by Country (USD MN)
  • Brazil Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Brazil Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Rest of Latin America Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Rest of Latin America Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Middle East & Africa Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Middle East & Africa Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Middle East & Africa Alzheimer’S Drugs Market Estimate by Country (USD MN)
  • Middle East Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Middle East Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Africa Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Africa Alzheimer’S Drugs Market Estimate by By Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
  • Research Scope of Alzheimer’S Drugs Report
  • Market Research Process
  • Market Research Methodology
  • Global Alzheimer’S Drugs Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by By Drugs
  • Market Attractiveness Analysis by By Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Alzheimer’S Drugs Market Analysis by By Drugs (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Donepezil by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Rivastigmine by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Galantamine by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Others by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis by By Distribution Channel (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Alzheimer’S Drugs Market Analysis in E-Commerce by Geography (USD MN)
  • Latin America Alzheimer’S Drugs Market by Revenue
  • Middle East & Africa Alzheimer’S Drugs Market by Revenue
  • Recent Development in Alzheimer’S Drugs Industry
  • Company Market Share Analysis, 2019
 
 * Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials